Rate-controlled drug delivery and the reduction of risk
There are several drugs which would not be on the market today were it not for their associated delivery systems. An old, but very good, example is the inhalation anaesthetic halothane. To use it safely requires a special vaporizer which enables the anaesthetist to ‘dial’ a fixed concentration of the agent in the patient’s inspired air. This delivery system not only makes halothane simpler to use than other agents, but also gives it a safety margin which it would not have if given by the open-drop inhalation method (which worked quite well for ether). Also, the halothane vaporizer has been used very artfully in promotion to persuade anaesthetists to use the new product. Today, 25 years after its introduction, halothane dominates the inhalation anaesthetic market in all technologically advanced countries, and the vaporizer has become an integral part of contemporary anaesthetic practice.
KeywordsDelivery System Drug Delivery System Market Today Special Drug Delivery Conventional Dose Form
Unable to display preview. Download preview PDF.
- 1.Heilmann K (1982) Therapeutische Systeme. 3rd Edition. Enke F. Stuttgart.Google Scholar
- 2.Heilmann K (1983) Therapeutic Systems. 2nd Edition. Thieme-Stratton New YorkGoogle Scholar
- 3.Urquhart J (ed.) (1981) Controlled-release pharmaceuticals. American Pharmaceutical Association, Washington. (A French edition is available from Editions Sante, 19 Rue Louis-le-Grand, Paris 75002.)Google Scholar
- 4.James BG (1982) The Marketing of Generic Drugs: a guide to counterstrategies for the technology intensive pharmaceutical companies. Associated Business Press, London. Scrip Bookshop, Richmond, England.Google Scholar